Monitoring platelet GP IIb/IIIa [corrected] antagonist therapy

Zalunfiban at First Medical Contact for ST-Elevation Myocardial Infarction.

NEJM evidence·2025

Differences in prevalence of community-associated MRSA and MSSA among U.S. and non-U.S. born populations in six New York Community Health Centers.

Travel medicine and infectious disease·2016

αIIbβ3: structure and function.

Journal of thrombosis and haemostasis : JTH·2015

Historical perspective and future directions in platelet research.

Journal of thrombosis and haemostasis : JTH·2011

Impact of sex, age, race, ethnicity and aspirin use on bleeding symptoms in healthy adults.

Journal of thrombosis and haemostasis : JTH·2010

Diversity of Glanzmann thrombasthenia in southern India: 10 novel mutations identified among 15 unrelated patients.

Journal of thrombosis and haemostasis : JTH·2006

Immune Checkpoint Inhibitor Myocarditis and Myotoxicity.

Circulation·2026

Impaired Glycolysis Leads to Defective Efferocytosis and Impaired Plaque Resolution in Tet2 Clonal Hematopoiesis.

Circulation·2026

Macrotroponin Complexes and Risk of Cardiovascular Events.

Circulation·2026

Arrhythmic Risk Stratification According to LGE Corridors and Genetics in Nonischemic Dilated Cardiomyopathy.

Circulation·2026

Infective Endocarditis: Diagnosis, Antibiotic Therapy, and Management: A Scientific Statement From the American Heart Association.

Circulation·2026

An Updated Evidence Assessment of the Genetic Causes of Dilated Cardiomyopathy.

Circulation·2026

The shake-test for adjuvanted vaccines: A manufacturer's perspective.

Journal of pharmaceutical sciences·2026

Zhangyanming Tablets for Dry Eye Disease: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Study.

Chinese journal of integrative medicine·2026

Doravirine/Islatravir: First Approval.

Drugs·2026

Proteolysis Targeting Chimeras (PROTACs): Design and Mechanism.

Handbook of experimental pharmacology·2026

PROTAC as a Potential Toolbox for the Discovery of New Targets and Drugs.

Handbook of experimental pharmacology·2026

High-Throughput Screen for Candidate PROTAC Identification.

Handbook of experimental pharmacology·2026

Related Experiment Videos

Monitoring platelet GP IIb/IIIa [corrected] antagonist therapy

Related Concept Videos

Zalunfiban at First Medical Contact for ST-Elevation Myocardial Infarction.

Differences in prevalence of community-associated MRSA and MSSA among U.S. and non-U.S. born populations in six New York Community Health Centers.

αIIbβ3: structure and function.

Historical perspective and future directions in platelet research.

Impact of sex, age, race, ethnicity and aspirin use on bleeding symptoms in healthy adults.

Diversity of Glanzmann thrombasthenia in southern India: 10 novel mutations identified among 15 unrelated patients.

Immune Checkpoint Inhibitor Myocarditis and Myotoxicity.

Impaired Glycolysis Leads to Defective Efferocytosis and Impaired Plaque Resolution in Tet2 Clonal Hematopoiesis.

Macrotroponin Complexes and Risk of Cardiovascular Events.

Arrhythmic Risk Stratification According to LGE Corridors and Genetics in Nonischemic Dilated Cardiomyopathy.

Infective Endocarditis: Diagnosis, Antibiotic Therapy, and Management: A Scientific Statement From the American Heart Association.

An Updated Evidence Assessment of the Genetic Causes of Dilated Cardiomyopathy.

The shake-test for adjuvanted vaccines: A manufacturer's perspective.

Zhangyanming Tablets for Dry Eye Disease: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Study.

Doravirine/Islatravir: First Approval.

Proteolysis Targeting Chimeras (PROTACs): Design and Mechanism.

PROTAC as a Potential Toolbox for the Discovery of New Targets and Drugs.

High-Throughput Screen for Candidate PROTAC Identification.

Related Experiment Videos

Monitoring platelet GP IIb/IIIa [corrected] antagonist therapy

Related Concept Videos

Related Articles